Brief: Senores Pharmaceuticals Acquires USFDA-Approved ANDA For Topiramate Tablets
05/05/2025 12:36
May 5 (Reuters) - Senores Pharmaceuticals Ltd SENO.NS: SENORES PHARMACEUTICALS LTD - ACQUIRES USFDA-APPROVED ANDA FOR TOPIRAMATE TABLETS SENORES PHARMACEUTICALS LTD - ACQUISITION FUNDED THROUGH IPO PROCEEDS Source text: ID:nBSE3m6TdK Further company coverage: SENO.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees